Biochemical Markers of Bone Turnover and Risk of Incident Diabetes in Older Women: The Cardiovascular Health Study
- PMID: 30002202
- PMCID: PMC6105330
- DOI: 10.2337/dc18-0849
Biochemical Markers of Bone Turnover and Risk of Incident Diabetes in Older Women: The Cardiovascular Health Study
Abstract
Objective: To investigate the relationship of osteocalcin (OC), a marker of bone formation, and C-terminal cross-linked telopeptide of type I collagen (CTX), a marker of bone resorption, with incident diabetes in older women.
Research design and methods: The analysis included 1,455 female participants from the population-based Cardiovascular Health Study (CHS) (mean [SD] age 74.6 [5.0] years). The cross-sectional association of serum total OC and CTX levels with insulin resistance (HOMA-IR) was examined using multiple linear regression. The longitudinal association of both markers with incident diabetes, defined by follow-up glucose measurements, medications, and ICD-9 codes, was examined using multivariable Cox proportional hazards models.
Results: OC and CTX were strongly correlated (r = 0.80). In cross-sectional analyses, significant or near-significant inverse associations with HOMA-IR were observed for continuous levels of OC (β = -0.12 per SD increment; P = 0.004) and CTX (β = -0.08 per SD; P = 0.051) after full adjustment for demographic, lifestyle, and clinical covariates. During a median follow-up of 11.5 years, 196 cases of incident diabetes occurred. After full adjustment, both biomarkers exhibited inverse associations with incident diabetes (OC: hazard ratio 0.85 per SD [95% CI 0.71-1.02; P = 0.075]; CTX: 0.82 per SD [0.69-0.98; P = 0.031]), associations that were comparable in magnitude and approached or achieved statistical significance.
Conclusions: In late postmenopausal women, lower OC and CTX levels were associated with similarly increased risks of insulin resistance at baseline and incident diabetes over long-term follow-up. Further research to delineate the mechanisms linking abnormal bone homeostasis and energy metabolism could uncover new approaches for the prevention of these age-related disorders.
© 2018 by the American Diabetes Association.
Figures
Similar articles
-
Biochemical markers of bone turnover and risk of incident hip fracture in older women: the Cardiovascular Health Study.Osteoporos Int. 2019 Sep;30(9):1755-1765. doi: 10.1007/s00198-019-05043-1. Epub 2019 Jun 21. Osteoporos Int. 2019. PMID: 31227885 Free PMC article.
-
Association of Insulin Resistance and β-cell Function With Bone Turnover Biomarkers in Dysglycemia Patients.Front Endocrinol (Lausanne). 2021 Mar 25;12:554604. doi: 10.3389/fendo.2021.554604. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33841321 Free PMC article.
-
Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study.J Bone Miner Res. 2003 Oct;18(10):1789-94. doi: 10.1359/jbmr.2003.18.10.1789. J Bone Miner Res. 2003. PMID: 14584889
-
Biochemical markers of bone turnover in diabetes patients--a meta-analysis, and a methodological study on the effects of glucose on bone markers.Osteoporos Int. 2014 Jun;25(6):1697-708. doi: 10.1007/s00198-014-2676-7. Epub 2014 Mar 28. Osteoporos Int. 2014. PMID: 24676844 Review.
-
Effect of vitamin D supplementation or fortification on bone turnover markers in women: a systematic review and meta-analysis.Br J Nutr. 2024 May 14;131(9):1473-1487. doi: 10.1017/S0007114524000060. Epub 2024 Jan 15. Br J Nutr. 2024. PMID: 38221822 Review.
Cited by
-
Biochemical markers of bone turnover and risk of incident hip fracture in older women: the Cardiovascular Health Study.Osteoporos Int. 2019 Sep;30(9):1755-1765. doi: 10.1007/s00198-019-05043-1. Epub 2019 Jun 21. Osteoporos Int. 2019. PMID: 31227885 Free PMC article.
-
The Role of Bone-Derived Hormones in Glucose Metabolism, Diabetic Kidney Disease, and Cardiovascular Disorders.Int J Mol Sci. 2022 Feb 21;23(4):2376. doi: 10.3390/ijms23042376. Int J Mol Sci. 2022. PMID: 35216490 Free PMC article. Review.
-
Impact of Diabetes Mellitus on Bone Health.Int J Mol Sci. 2019 Sep 30;20(19):4873. doi: 10.3390/ijms20194873. Int J Mol Sci. 2019. PMID: 31575077 Free PMC article. Review.
-
Roles for osteocalcin in brain signalling: implications in cognition- and motor-related disorders.Mol Brain. 2019 Mar 25;12(1):23. doi: 10.1186/s13041-019-0444-5. Mol Brain. 2019. PMID: 30909971 Free PMC article. Review.
-
Evaluating the association between lifestyle factors and heel bone mineral density in different inflammatory states.Heliyon. 2024 Jun 22;10(13):e33435. doi: 10.1016/j.heliyon.2024.e33435. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39040264 Free PMC article.
References
-
- Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007;22:465–475 - PubMed
-
- Khan MP, Singh AK, Joharapurkar AA, et al. . Pathophysiological mechanism of bone loss in type 2 diabetes involves inverse regulation of osteoblast function by PGC-1α and skeletal muscle atrogenes: AdipoR1 as a potential target for reversing diabetes-induced osteopenia. Diabetes 2015;64:2609–2623 - PubMed
-
- Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 2007;166:495–505 - PubMed
-
- Ishimi Y, Miyaura C, Jin CH, et al. . IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990;145:3297–3303 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 HL080295/HL/NHLBI NIH HHS/United States
- U01 HL130114/HL/NHLBI NIH HHS/United States
- HHSN268200800007C/HL/NHLBI NIH HHS/United States
- N01HC55222/HL/NHLBI NIH HHS/United States
- N01HC85086/HL/NHLBI NIH HHS/United States
- HHSN268200800001C/AR/NIAMS NIH HHS/United States
- N01HC85082/HL/NHLBI NIH HHS/United States
- N01HC85083/HL/NHLBI NIH HHS/United States
- K24 HL135413/HL/NHLBI NIH HHS/United States
- N01HC85080/HL/NHLBI NIH HHS/United States
- N01HC85081/HL/NHLBI NIH HHS/United States
- HHSN268201200036C/HL/NHLBI NIH HHS/United States
- HHSN268201800001C/HL/NHLBI NIH HHS/United States
- N01HC85079/HL/NHLBI NIH HHS/United States
- R01 AG023629/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical